ORTEXORTEX News
Tracking UROY? Get live short interest, options flow, and signals on ORTEX.Sign up free →
UR
Earnings PreviewUROY

Uranium Energy's Shadow Looms Over UROY's Earnings Day

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 15 Sept 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit
ORTEX chart of Uranium Royalty Corp. (UROY) share price and short interest (% of free float), three months to September 11, 2026
ORTEX data as of 15 Sept 2026, 04:00

Uranium Royalty Corp. heads into its September 15 earnings print with an activist shareholder quietly stepping back — and the stock trading 36% above where its CEO was buying shares just six weeks ago.

The most newsworthy fact in UROY's current setup is the registered 13D activist on the share register. Uranium Energy Corp holds a 7.7% stake, down sharply from 18.4% at the time of its previous disclosure — a reduction of more than half, last filed July 28. That kind of drawdown from a 13D filer signals a meaningful strategic shift. Uranium Energy's original 13D filing in May flagged activist intent; its amended position now raises questions about that relationship heading into the print. As always with 13D/G disclosures, stakes are as last disclosed and holders can fall below 5% without a further filing, so the current position may differ further still.

The insider picture offers a modest counter-signal. CEO Scott Melbye made three open-market purchases on July 30 — all discretionary, none under a 10b5-1 plan — at prices around $3.12, totalling roughly $43,300. The stock has since climbed to $4.24, up nearly 36% from those levels. That move has outpaced most correlated peers: HYMC fell over 9% on the week, AGX dropped 11%, and the broader group was mostly lower. UROY's own one-week decline of 4.5% looks comparatively contained, though the one-month gain of 2.9% is modest against the backdrop of a recovering uranium complex.

Short interest tells an unambiguous story of bears stepping away. Positions have been cut by nearly half over the past month, with SI % of free float falling to roughly 2% — well within low territory. The borrow market corroborates that read: availability is ample at around 565% of short interest, and the cost to borrow has dropped from above 2.5% in early August to under 0.75%, the lowest level in the tracked period. Options positioning is equally calm — the put/call ratio of 0.25 is barely a fraction below its 20-day average, showing no meaningful hedging activity ahead of the print.

The analyst consensus points to a mean price target of $5.91 against the current $4.24, with the bear case centred on P/NAV compression driven by a weaker uranium pricing environment — a multiple that reportedly fell from 2.40x to 1.50x. The bull case rests on royalty exposure to Tier 1 assets including McArthur River, Langer Heinrich, and Cigar Lake, combined with a dramatic forward earnings inflection — factor data points to nearly 306% year-on-year EPS growth expected ahead. With Uranium Energy's reduced commitment now on the table, tonight's print is less about the royalty portfolio's underlying quality and more about whether management can articulate a credible path forward without the sector's most visible strategic backer.

Against its own history

This week's change in short interest is 2.2 standard deviations below the company's typical weekly move over the past year. Short interest is at its lowest level in at least a year.

Against its peers

Shares moved -4.5% over the past week against a median of -4.6% for its closest peers.

Stocks in this article

See the live data behind this article on ORTEX.

Open UROY on ORTEX →

How this article was generated

Generated
15 Sept 2026, 04:01
Data as of
15 Sept 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.